Novel reverse genetics approach to probe cytoskeletal functions in mammalian oocytes

探测哺乳动物卵母细胞细胞骨架功能的新型反向遗传学方法

基本信息

  • 批准号:
    10018066
  • 负责人:
  • 金额:
    $ 7.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-13 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Actin cytoskeleton-based processes play crucial roles in meiosis in mammalian oocytes, including positioning of the meiotic spindle and asymmetric cell division. These events in oocytes are essential for reproductive success, as gene knockouts that impair these processes cause female infertility. The overall goal of the research proposed here is to analyze the roles of key proteins hypothesized to modulate function of the actin cytoskeleton during female meiosis. The hypotheses to be pursued here are based on our published data and on new unpublished data presented here. A second goal of this project is a technical one – to provide valuable proof-of-principle demonstration of the utility of a novel system for post- translational protein depletion, as an asset to the oocyte biology research community. Standard approaches for protein depletion that are used in oocytes (i.e., knockout, knockdown) have relatively little temporal precision for depletion of the target of interest. In contrast, consider the following example, from study in budding yeast. Chronic depletion of a protein via a null mutation merely produced a slow growth phenotype, whereas depletion at a specific stage of meiosis provided much sharper insights with a much more specific and interesting phenotype. This is the inspiration for the project proposed here. This research will use this same innovative approach – the auxin-inducible degradation (AID) system – to gain new insights into the mammalian oocyte's progression through meiosis. We show here that we have the AID system up and running in mouse oocytes. The overall concept for these studies is to express function- altering variants of proteins of interest (dominant-negative [DN] or constitutively-active [CA]) in wild-type oocytes to perturb function of a particular pathway. The AID system allows for degradation of this function- altering protein at different times of meiotic maturation (e.g., M-phase entry [nuclear envelope breakdown], early M-phase, late M-phase, etc.). In essence, this converts oocytes from a mutant state to wild-type at a time of our choosing, allowing temporal specificity in assessing protein function. We will use the AID system to analyze different stages of oocyte meiosis, from entry into M-phase of meiosis I to the conclusion of meiosis II. Thus, this project will be valuable not only for the discoveries it will provide, but also for the demonstration of AID system utility at multiple stages of meiosis. Aim 1 focusses on spindle positioning in meiosis I, and will determine the role of the actin-depolymerization protein cofilin through studies of when and where cofilin is required for spindle positioning. Aim 2 examines meiosis I, metaphase II arrest, and completion of meiosis II, and will test the hypothesis that inappropriate activity of the actin-to- membrane linker protein family known as ERMs impairs spindle function and polar body emission. Taken together, these studies will provide important insights to advance understanding of these crucial actin- dependent processes in oocytes, including leading to future work in in vivo models.
项目总结 基于肌动蛋白细胞骨架的过程在哺乳动物卵母细胞的减数分裂中起着至关重要的作用,包括 减数分裂纺锤体的定位和细胞的不对称分裂。卵母细胞中的这些事件对于 生殖成功,因为破坏这些过程的基因敲除会导致女性不育。整体而言 这项研究的目的是分析被假设为调节功能的关键蛋白质的作用。 在雌性减数分裂过程中肌动蛋白细胞骨架的变化。这里将要进行的假设是基于我们的 已发布的数据和此处提供的新的未发布的数据。这个项目的第二个目标是技术上的 一是提供有价值的原则证明,证明一种新的邮寄系统的实用性。 翻译蛋白耗竭,作为卵母细胞生物学研究社区的一项资产。标准 用于卵母细胞的蛋白质耗竭方法(即基因敲除、基因敲除)相对较少。 目标耗尽的时间精度。相比之下,请考虑下面的示例,其中 芽殖酵母的研究。蛋白质通过零突变的慢性耗尽只会产生缓慢的生长 表型,而减数分裂特定阶段的耗竭提供了更敏锐的洞察力 更具体和有趣的表型。这就是这里提出的项目的灵感来源。这 研究将使用同样的创新方法-生长素诱导降解(AID)系统-来获得 对哺乳动物卵母细胞减数分裂过程的新见解。我们在这里展示了我们拥有 小鼠卵母细胞中辅助系统的启动和运行。这些研究的总体概念是表达函数- 改变野生型中感兴趣的蛋白质的变体(显性负性[dN]或结构性活性[CA]) 卵母细胞扰乱特定途径的功能。AID系统允许该功能的降级- 在减数分裂成熟的不同时间改变蛋白质(例如,M期进入[核膜破裂], 早期M期、晚期M期等)。从本质上讲,这将卵母细胞从突变状态转变为野生型 在我们选择的时间,允许在评估蛋白质功能时具有时间特异性。我们将使用 用于分析卵母细胞减数分裂不同阶段的AID系统,从进入减数分裂I的M期到 减数分裂的结论二。因此,这个项目不仅有价值,因为它将提供的发现,而且 也用于演示AID系统在减数分裂多个阶段的实用性。目标1专注于主轴 定位在减数分裂I,并将确定肌动蛋白解聚蛋白的作用通过 研究何时何地需要胶原蛋白来定位主轴。目的2检查减数分裂I、中期 II停止,并完成减数分裂II,并将检验以下假设:不适当的肌动蛋白到- 膜连接蛋白家族被称为ERMS,会损害纺锤体功能和极体发射。已被占用 总之,这些研究将为促进对这些关键肌动蛋白的理解提供重要的见解。 卵母细胞中的依赖过程,包括在活体模型中的未来工作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JANICE P EVANS其他文献

JANICE P EVANS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JANICE P EVANS', 18)}}的其他基金

The oocyte's progression through meiosis: Involvement of a heart disease-associated protein
卵母细胞减数分裂的进展:心脏病相关蛋白的参与
  • 批准号:
    10636839
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
The oocyte's progression through meiosis: Involvement of a heart disease-associated protein
卵母细胞减数分裂的进展:心脏病相关蛋白的参与
  • 批准号:
    10415975
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
The oocyte's progression through meiosis: Involvement of a heart disease-associated protein
卵母细胞减数分裂的进展:心脏病相关蛋白的参与
  • 批准号:
    10018056
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
The oocyte's progression through meiosis: Involvement of a heart disease-associated protein
卵母细胞减数分裂的进展:心脏病相关蛋白的参与
  • 批准号:
    10189671
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
p21-activated kinase as regulator of actin and microtubules in mammalian oocytes
p21 激活激酶作为哺乳动物卵母细胞肌动蛋白和微管的调节剂
  • 批准号:
    9387058
  • 财政年份:
    2017
  • 资助金额:
    $ 7.75万
  • 项目类别:
Signaling pathways that mediate mammalian oocyte cortical mechanics
介导哺乳动物卵母细胞皮质力学的信号通路
  • 批准号:
    8583163
  • 财政年份:
    2013
  • 资助金额:
    $ 7.75万
  • 项目类别:
Signaling pathways that mediate mammalian oocyte cortical mechanics
介导哺乳动物卵母细胞皮质力学的信号通路
  • 批准号:
    8701324
  • 财政年份:
    2013
  • 资助金额:
    $ 7.75万
  • 项目类别:
Novel approaches for disrupting gene expression in mammalian oocytes
破坏哺乳动物卵母细胞基因表达的新方法
  • 批准号:
    8195724
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
alpha-endosulfine in mammalian oocyte meiotic maturation
α-硫辛在哺乳动物卵母细胞减数分裂成熟中的作用
  • 批准号:
    8191837
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
2011 Fertilization and Activation of Development Gordon Research Conference
2011年施肥与发育激活戈登研究会议
  • 批准号:
    8198031
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了